Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia Ian M. BoulignyGraeme MurrayKeri R. Maher Original Paper 23 February 2024 Article: 80
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma Yu-Ting YinLu ShiShi-Juan Mai Original Paper 23 February 2024 Article: 79
Estrogen-related receptor alpha (ERRα) promotes the migration, invasion and angiogenesis of breast cancer stem cell-like cells Kartik MuduliJagannath PradhanSelvakumar Elangovan Original Paper 23 February 2024 Article: 78
Correction to: Exploring the advances of single‑cell RNA sequencing in thyroid cancer: a narrative review Joecelyn Kirani TanWireko Andrew AwuahDenys Ovechkin Correction Open access 23 February 2024 Article: 77
Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS) Alexander S. TaylorRahul MannanRohit Mehra Original Paper Open access 23 February 2024 Article: 76
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity Qiang YouRong LiYang Yang Review Article 21 February 2024 Article: 75
Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial carcinoma of bladder as a potential therapeutic target David RajaAishwarya SinghPrabhjot Singh Original Paper 20 February 2024 Article: 74
Advancements in biosensors for cancer detection: revolutionizing diagnostics Syed Khalid MustafaMohd. Farhan KhanSadanand Pandey Review Article 19 February 2024 Article: 73
CRP inhibits the osteoblastic differentiation of OPCs via the up-regulation of primary cilia and repression of the Hedgehog signaling pathway Jie XuXiangmei WuChangdong Wang Original Paper 12 February 2024 Article: 72
Selective targeting or reprogramming of intra-tumoral Tregs Keywan Mortezaee Review Article 11 February 2024 Article: 71
The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study Abbas AlalikhanSafieh EbrahimiSeyed Isaac Hashemy Original Paper 10 February 2024 Article: 70
A therapeutical insight into the correlation between circRNAs and signaling pathways involved in cancer pathogenesis Raed Obaid SalehSulieman Ibraheem Shelash Al-HawaryAli Alsalamy Review Article 04 February 2024 Article: 69
Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment Parinaz AkbariMohammad TaebpourSadanand Pandey Original Paper 30 January 2024 Article: 68
Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment Nathan A. HainesMia G. FowlerYujiang Fang Review Article 29 January 2024 Article: 67
Pyroptosis in cancer treatment and prevention: the role of natural products and their bioactive compounds Liyi WuLina ShanBingjun Bai Review Article 28 January 2024 Article: 66
Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1 Jackie L. HaErin KaserYujiang Fang Original Paper 28 January 2024 Article: 65
Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway: a combinational drug approach Gobika ArumugamSangilimuthu Alagar Yadav Original Paper 27 January 2024 Article: 64
C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation Mesfer Al ShahraniReem M. GahtaniMohammed Makkawi Original Paper 24 January 2024 Article: 63
